T-box transcription factor 19 (TBX19)

T-box transcription factor 19 (TBX19, also known as TPIT) is a sequence-specific DNA-binding transcription factor that belongs to the T-box family. It contains a characteristic T-box DNA-binding domain and serves as a key developmental regulator in the pituitary gland. TBX19 is selectively expressed in precursors of corticotrope and melanotrope lineages, marking cells that will express the pro-opiomelanocortin (POMC) gene, which encodes precursor peptides for adrenocorticotropic hormone (ACTH) and melanocyte-stimulating hormone (MSH). TBX19 can activate POMC gene expression in synergy with other transcription factors (such as Pitx1/Pitx2) and represses alternative lineages by inhibiting αGSU and TSHβ gene expression. Its critical DNA-binding activity is required for its regulatory functions. Loss-of-function mutations in TBX19/TPIT are associated with inherited ACTH deficiency, highlighting its role in endocrine development rather than as a direct drug target[1][2]. Note: TBX19/TPIT is not currently a direct target of approved therapeutic drugs. Its disease relevance focuses on genetic deficiency leading to hormone insufficiency.

Other names

T-box transcription factor TBX19TBX19TPITT-box protein 19dj747L4.1T-box factor pituitaryTBS 19TBS19dJ747L4.1T-box 19

No drugs currently known to target TBX19 directly; it acts mainly as a transcriptional regulator